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Abstract 
The aim of study is to formulate Thymoquinone gel and investigate its effect in chronic periodontitis in terms 
of clinical periodontal parameters, anti-oxidant capacity and the levels of IL-1β in gingival crevicular fluid. 
different gelling agents (carbopol, hydroxyl propyl methyl cellulose and chitosan) were used for the 
development of TQ gel. The optimized gel formulation was used for the clinical study. The study was conducted 
on 68 subjects (25-58 years old). 48 patients were clinically diagnosed with moderate to severe chronic 
periodontitis. Patients were divided into three groups; Group I (24 patients): received non-surgical periodontal 
therapy and Thymoquinone-chitosan gel (0.1 % w/w), Group II (24 patients): received only non-surgical 
periodontal therapy and Group III: 20 healthy subjects (control group). All patients were evaluated for clinical 
parameters including plaque index (PI), gingival index (GI), probing depth (PD) and clinical attachment level 
(CAL).  The levels of IL-1β and total anti-oxidant capacity were recorded in gingival crevicular fluid at baseline 
(prior to treatment) and at weeks 4 and 12 after treatment. The results showed that combination of non-surgical 
periodontal therapy and Thmoquinone gel (group I)  exhibited statistically significant improvement in 
biochemical parameters compared to non-surgical periodontal therapy alone (group II). 
------------------------------------------------------------------------ 
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In conclusion we can say that the adjunctive use of thymoquinone gel with non-surgical periodontal therapy 
improves the biochemical parameters accompanied with chronic periodontitits significantly after 4 weeks only. 
Key words: periodontitis; TQ; bioadhesive gel;  IL-1β; clinical parameters. 
1. Introduction 
Nigella sativa or black seed is an annual plant of the Ranunculaceae family. Nigella sativa seeds contain a 
variety of well-known active compounds with many pharmacological effects[1]. Thymoquinone (TQ) is the 
main bioactive constituent of Nigella sativa oil. It exhibits numerous pharmacological properties, including,  
ant-ibacterial, anti-inflammatory, anti-histaminic, anti-oxidant  and hypoglycemic actions [2, 3].  Periodontitis is 
a chronic inflammatory disease, characterized by gingival bleeding, periodontal pocket formation, connective 
tissue destruction and alveolar bone resorption which may result in tooth loss. Although oral bacteria, and their 
toxins, enzymes and metabolites, are considered to be the main causative factors for the initiation of 
inflammatory processes, the host inflammatory response is primarily responsible for the progression of the 
disease and for most of the connective tissues destruction [4, 5]. Inflammatory mediators are important to the 
pathogenesis of periodontal diseases and may be used as diagnostic markers. Interleukin (IL)-1 is present in two 
active forms, IL-1α and IL-1β. Both are potent Pro-inflammatory molecules and are the main components of 
osteoclast activating factor [6]. Reactive oxygen species (ROS) have been implicated in the pathogenesis of 
many inflammatory diseases, including rheumatoid arthritis[7], chronic obstructive pulmonary disease [8], 
atherosclerosis[9] and periodontal disease[10].  The total antioxidant capacity (TAOC) has been widely used to 
investigate OS in periodontal disease. It is an integrated parameter that reflects the cumulative activity of 
nonenzymatic antioxidants present in the plasma and body fluids[11]. Many treatment modalities are available 
to achieve the goal of periodontal therapy. This includes nonsurgical periodontal therapy, such as scaling and 
root planing (SRP) alone or SRP plus systemic or local antimicrobial/anti-inflammatory agents, and surgical 
periodontal therapy[12].   Bioadhesive gels for buccal application should  maintain  suitable mechanical  and 
rheological  properties,  including good  spreadability,   suitable PH for buucal environment, appropriate  
hardness, pseudoplastic  or  plastic  flow  with  thixotrophy,  and prolonged residence time [13]. These 
properties may enhance the patient compliance and adherence to administration instructions.   Moreover, the 
leaky epithelium of the buccal region would enhance the absorption of applied drugs. Avoidance of enzymatic 
degradation and maximized absorption as aresult of the copious blood supply are valuable advantages of buccal  
route of drug delivery. Conversely, the application of common dosage forms such as creams, ointments, 
solutions, and onto the oral mucosa is counteracted by salivation, swallowing and tongue movement.  Hence, 
new applicable formulations with controlled release should be considered.    The  mucoadhesive  dosage forms  
prepared using  certain  water-soluble  polymers  maintain adhesiveness on hydration and e can be utilized for 
targeting the delivery drugs to  certain  region  of  the  body. The ultimate performance of buccal  preparations  
and  their  acceptance by patients are dependent on their  suitable  rheological, pseudoplastic  or  plastic  flow  
with  thixotrophy,  ease  of application,  good  spreadability,  and  extended  residence time in the oral cavity.  In 
the present study, bioadhesive gel-forming  agents with  suitable  gelation  temperature  like  Carbopol  and 
Poloxamer were used for  excellent  thick  gel  barrier  formation characteristics  [14]. The prepared TQ gel was 
evaluated for its effect on the clinical periodontal parameters as well as the level of IL-1β and total anti-oxidant 
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capacity levels in gingival crevicular fluid of chronic periodontitis patients. 
2. Materials and methods 
2.1. Materials 
Thymoquinone (2-isopropyl-5-methylbenzo-1, 4-quinone) > 99 % was purchased from Sigma-Aldrich (St. 
Louis, MO, USA).  Carbopol  934 was  purchased  from  Lobo  Chemie  Pvt.  Ltd.,  India.  Poloxamer 811   was 
purchased  from  Himedia  Lab  Pvt .Ltd.,  India. Deionized water was supplied by the microbiological 
laboratory for water and food analysis (Minia, Egypt).   All  other  chemicals  used  in  the  study  were  of 
analytical grade. 
2.2. Methods 
2.2.1. Preparation of Thymoquinone bioadhesive gel 
Carbopol-poloxamer gel of 1% thymoquinone was prepared as follows:  minimum amount of water was added 
to Poloxamer 188 (2%) at 5°C with gentle stirring[15].   Subsequently, TQ was added with minimal amount of 
ethanol to the poloxamer solution.  An aqueous suspension of Carbopol  934  (5%)  was  stirred  with in  a  
separate  beaker and  added  to  the prepared  solution  of  Poloxamer-TQ  and  stirred  for 1h. The preparation 
was then adjusted to 25 ml with distilled. 
2.2.2. Characterization of TQ bioadhesive gel 
2.2.2.1. Measurement of gelation temperature 
Two  grams  of  TQ  gel  was  placed  in  a  100  ml beaker  above  a  low-temperature  thermostat water bath. 
Prepared gel was continuously stirred at 50 rpm at with increasing the temperature by the rate of 5°C/5 min [16]. 
The temperature at which the magnet stopped moving as a result of gelation was recorded as the gelation 
temperature.  
2.2.2.2. Determination of bioadhesive force 
The bioadhesive force of the prepared TQ gel was determined using a modified balance[17].  Minimal weights 
required for detaching the mucosal side of goat buccal tissue secured on two vials and enclosed by the prepared 
gel was recoreded as the bioadhesive force. 
2.2.2.3. Rheological  study 
Clarity of the prepared gel formulation was evaluated through visual inspection against black and white 
backgrounds. pH of the prepared formulation was measured using pH meter. Experiments were carried out in 
triplicates and the pH result were the average of the three determinations. Moreover, the rheological profiles of 
the prepared gel formulation were studied and recorded using Anton paar rheometer (RHEOPLUS/32 V3.40 
software). Alternating rotational speed of the rheometer spindle (1 to 50 rpm) was applied to perform different 
shear rates. The viscosity at a given shear rate was determined at 37±1 
O
C and plotted against rate of shear.  
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2.2.3. Ex- vivo permeation of drug through the buccal mucosa 
Ex- vivo permeation studies were performed using Freshly excised goat buccal tissue within 2 h of removal 
[18]. Surgical scissors were used for removing the underlying tissues keeping the basal membrane intact.  The 
prepared buccal mucosa was  then  stored  at  4°C  for  24  h  in  phosphate buffered  saline  pH 6.8. Modified 
Franz diffusion cells were used for the permeation study . Specially designed diffusion tubes with goat buccal 
mucosa at one end were used by placing Two g gel inside. This  was  immersed  in  a  beaker  containing  20mL  
of  Phosphate  buffer (pH  6.8)  and  was  shaken in  thermostatically  controlled  magnetic stirrer at 37±1°C. 
Cumulative amount permeated of TQ was determined spectrophotometry at 256 nm. The  release  data  of  TQ 
gel   was  fitted  to  zero-order,  first-order,  and  Higuchi  equations  to  determine  the  kinetic model of drug 
release. 
2.2.4. Clinical study 
To gain more insight into the effect of the combination of application of TQ bioadhesive gel  and non-surgical 
periodontal therapy on the improving the periodontal clinical parameters, sixty eight subjects of both sexes with 
age ranged 25-58 years old were divided into three groups: Group I: healthy subjects (control group), Group II: 
24 patients with moderate to severe chronic periodontitis received only non-surgical periodontal therapy 
including three sessions of full mouth supra and sub gingival scaling and root planning (SRP) using hand 
instruments and ultrasonic scalers , Group III: 24 patients with moderate to severe chronic periodontitis received 
non-surgical periodontal therapy combined with TQ gel treatment where Periodontal pockets were filled with 
the TQ gel 0.1 % (w/w) immediately after completion of SRP using a blunt sterile needle until the gel could be 
observed at the gingival margin. The gel was reapplied after 48 hours and the gel applied sites were covered 
with a periodontal pack for 7 days. The patients were instructed to keep their oral hygiene procedures except the 
sites covered with dressing and after the removal of the dressing the operation site was washed with sterile 
saline.  Subjects were selected from the out patients clinic of the Oral Medicine, Oral Diagnosis, and 
Periodontology Department. Faculty of Dentistry, Minia University. The complete treatment protocol was 
explained to all patients and their full signed consent was obtained. The study was fulfilled with the rules set by 
the International Conference of Harmonization Good Clinical Practice Guidelines, and the Declaration of 
Helsinki and the research ethics committee of the Faculty of Dentistry, Mini University. 
2.1.4.1. Evaluation of clinical parameters 
Plaque index (PI), gingival index (GI), probing depth (PD) and clinical attachment level (CAL) were recorded at 
baseline (prior to treatment) and after 4 and 12 weeks of treatment in group II and III. 
2.1.4.2. Determination of IL-1β and TAOC levels in gingival crevicular fluid (GCF) 
Samples were collected from the GCF of the three groups at baseline, 4 weeks and 12 weeks after treatment.  
Samples were collected using Whatman3MM Chromatography (Wh.3MM) absorbent filter paper strips at 
baseline, 4 and 12 weeks. The supragingival plaque was isolated from maxillary teeth to avoid contamination 
with saliva. Buccal sites only were used to collect GCF samples to ensure approachability and the areas were 
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gently air dried. The paper strip was inserted into the gingival crevice up to 1 mm so that mild resistance was 
felt and keptt in the crevice for 30 seconds. The strips were individually stored in plastic Eppendorf and at - 20º 
C kept for further investigations. GCF from filter paper strips was diluted with the Reaction Buffer and ultra-
filtered through a 10,000 MWCO filter then used directly in the assay. Samples were incubated and centrifuged 
at 4°C. Commercially available Enzyme linked immune-sorbent assay (ELISA) kits were utilized, and assays 
were applied according to the manufacturers’ instructions to examine the level of IL-1β and TAOC. 
3. Results 
3.1. Evaluation of bioadhesive gel of TQ 
3.1.2. Gelation temperature 
Gellation of Poloxamer-cabopol gel of TQ occurred at 35 ºC and that was in continenece with a previous study 
that reported that combination of carpobol 934 with poloxamer 188 increases the gelling temperature of 
poloxamer to the physiological temperature [17]. Physically the prepared gel formulation was clear, 
homogenous, and the pH was ranging from 5 to 5.3 suggesting suitability to skin application. 
3.1.2. Bioadhesive force 
The buccal mucosal membranes are composed of oligosaccharide chains which can bind with polymers 
containing hydrophilic groups with certain bioadhesive force. Results show that TQ bioadhesive gel maintained 
a moderate bioadhesive force of 42 g force.   
3.1.3. Rheological study 
The prepared gel formulation exhibited pseudo-plastic behavior where viscosity is decreased by increasing the 
shear rate (Figure 1). Pseudopalstic behavior is favorable in pharmaceutical gel preparations to allow neat 
preparation, good spreadability, proper handling, and application on the skin. 
 
Figure 1: Shear rate-viscosity diagram of TQ- gel 
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3.2. Ex-vivo permeation 
 
Figure 2: Cumulative percentage released of TQ gel 
Table 1: kinetic evaluation of release data 
Formulation zero-order First-order Higuchi 
TQ gel 0.9654 0.9732 0.9934 
Release of TQ from the prepared gel is shown in figure 2. About 60 % of TQ was released through goat buccal 
membrane within the first 10 hours and reached 90% after 50 hours. The release through buccal mucosa 
exhibited a higuchi model (Table 1). 
3.3. Clinical study 
3.3.1. Clinical parameters 
The clinical parameters including gingival index (GI), probing depth (PD) and clinical attachment level (CAL) 
were recorded at baseline (prior to treatment) and at weeks 4 and 12 after treatment in group I and II. Both 
groups showed significant improvement regarding all clinical parameters from baseline to 4 and 12 weeks after 
treatment. The changes in the clinical parameters of the two studied patients groups are summarized in table 2.  
Table 2: percentage improvement in clinical parameters in group II and group III at different intervals. 
 Groups GI 
 
CAL 
 
PD 
 
4 weeks 12 weeks 4 weeks 12 weeks 4 weeks 12 weeks 
Group II 47.96+0.2 
% 
71.9+ 0.15 
% 
21.71+ 
0.50 % 
47.7+0.35 
% 
29.19+ 
0.043 % 
50.93+0.02 
% 
Group III 
 
49.95+0.05 
% 
75.27+0.83 
% 
27.72+0.03 
% 
58.5+0.081 
% 
33.94+0.2 
% 
56.9+0.13 
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3.3.2. Biochemical evaluation evaluation of IL-1β  and TAOC levels in GCF 
 The collected samples from the GCF of group I, group II and group III at baseline, 4 weeks and 12 weeks after 
treatment were examined for the level  of IL-1β and TAOC  using Commercially available Enzyme linked 
immunosorbent assay (ELISA) kits. Changes in the mean values of IL-1β at baseline and at different intervals in 
groups I, II and III were shown in table (3). Results show significant reduction in IL-1β after four weeks of 
treatment with combined clinical treatment and TQ gel (group III) compared to single clinical treatment (group 
II), P <0.0001. A consecutive significant reduction in levels of TAOC was determined in group III compared to 
group II, P <0.0001 (table 4). 
Table 3: Independent sample t- test to compare IL-1 β, between group I, group II and group III at different 
intervals. 
IL-1 β (pg/µl) Group I Group II 
Mean±SD 
Group III  
Mean±SD 
P value (II versus 
III) 
Baseline 103. 2±12.5 230.49±24.73 233.99±25.11 0.6 
 After 4 weeks 102.42±10.4 153.26±27.31 125.54±19.21 <0.0001 
After 12 weeks 102.1±11.25 106.04±9.51 103.95±10.84 0.4 
Table 4: Independent sample t- test to compare TAOC, between group I, group II  and group III at different 
point of time 
TAOC (µm/l)  Groups P-value (II versus 
III) Group I Group II  
Mean±SD 
Group III 
Mean±SD 
Baseline 843.33±22.52 644.22±17.02 647.37±22.06 0.5 
After 4 weeks 840.43±11.5 723.91±12.62 739.54±15.88 <0.0001 
After 12 weeks 838.2±20.3 762.96±12.84 773.73±14.68 0.01 
 
4. Discussion 
Pharmacological investigations of Nigella Sativa seed extracts reveal that Thymoquinone (the main active 
constituent) possess a broad spectrum of activities including antioxidant,  anti-inflammatory[19, 20] and 
antimicrobial potential against both Gram-positive and Gram-negative bacteria[21]. The main hypothesis of this 
work is to estimate and maximize the potential of this cargo in the treatment of periodontitis (an inflammatory 
disease leads to local elevation in levels of pro-inflammatory cytokine which plays a vital role in the process of 
inflammation associated with the destruction of the periodontium[22, 23]. A bioadhesive TQ gel was prepared 
using poloxamer 188 and carbopol 934 first to sustain the rate of release of TQ so that the preparation could be 
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applied twice only, and second to increase the contact time of the gel with buccal mucose and counteract the 
flushing effect of saliva. The gelation of the prepared bioadhesive gel occurred at 35°C so gelation occurs after 
biological application and not at the room temperature. Addition of carbopol 934 kept the well-arranged zigzag 
configuration of Poloxamer 188 and allowed gelation at 35°C [17]. The gel showed an optimum bioadhesive 
force which was enough to keep the drug in contact with the mucosal membrane without any damage for the 
mucous membranes. The pH of the TQ gel kept fairly constant the range of pH (6.7–7.0) along the 6-h test 
period, approving Suitability of the prepared gel to the natural environment of the Buccal acvity (pH 5.8–7.1). 
The controlled drug diffusion via the buccal mucosa can be attributed to the marked swelling of Carbopol  934  
which extensively creates a thick gel barrier. The prepared TQ gel combined with non-surgical periodontal 
treatment was evaluated in terms of enhancement of clinical periodontal parameters and reduction of anti-
inflammatory mediators (IL-1β) [24]and elevation of anti-oxidative stress (TAOC) [25]. Results show that either 
single non-surgical periodontal treatment alone or combined with TQ bioadhesive gel treatment would 
significantly enhance the Periodontal probing depth, clinical attachment level, gingival index and plaque index 
compared to the control group. The enhancement in the clinical parameters was more pronounced in the groups 
received combined treatment (group III). The improvement of clinical parameters in both groups may be due to 
the non-surgical clinical therapy. Scaling and root planning approach is efficient in reducing the magnitude of 
calculus and bacterial biofilm adherent to the sub-gingival surface [26]. The superior improvement of the 
clinical parameters owing to combined treatment could be attributed to the synergistic anti-oxidant and anti-
inflammatory effect of the sustained-released TQ of the bioadhesive gel. Considering the biochemical 
mediators, the elevated the baseline  levels of IL-1β in patients with periodontitis (groups II, III) compared to 
the control group (group I) was in consistence with   other studies [27, 28]. IL-1β concentration in GCF was 
significantly decreased in both groups after 4 and 12 weeks of treatment compared to the base line concentration 
of each individual group. Levels of TAOC have been significantly increased in the after 4 and 12 weeks of 
either single or combined treatment compared to baseline. Groups received combined treatment shows 
significant enhancement in the levels of biochemical parameters after four weeks compared to the biochemical 
parameters of the group with the single non-surgical clinical treatment only. However, the improvement was not 
significant after 12 weeks of treatment, this may be attributed to physical instability and photosensitivity of TQ 
[29]and, binding to plasma proteins of TQ (more than 99%) [30].  
5. Conclusions 
Combined treatment of periodontitis with non-surgical clinical treatment and bio-adhesive thymoqinone gel 
shows significant enhancement in the biochemical parameters of periodontitis after 4 weeks of treatment 
compared to single non-surgical periodontal therapy. Combined treatment has failed to keep that significant 
improvement following 12 weeks of treatment due to the physical instability of the drug.  Further studies are 
managed by our lab. including the development of an advanced  nanocarrier system  to enhance the 
physicochemical properties and pharmacokinetics of the drug via microencapsulation.  
6. Recommendation 
Further studies are to be attempted to encapsulate TQ within nanocarrier dosage forms to enhance its stability  
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